Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Celsion Corp (CLSN)

Celsion Corp (CLSN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 96,079
  • Shares Outstanding, K 86,558
  • Annual Sales, $ 500 K
  • Annual Income, $ -21,480 K
  • 60-Month Beta 1.96
  • Price/Sales 202.55
  • Price/Cash Flow N/A
  • Price/Book 1.84
Trade CLSN with:

Options Overview

Details
  • Implied Volatility 261.40%
  • Historical Volatility 59.79%
  • IV Percentile 48%
  • IV Rank 21.80%
  • IV High 865.77% on 10/20/20
  • IV Low 92.96% on 07/22/21
  • Put/Call Vol Ratio 0.08
  • Today's Volume 129
  • Volume Avg (30-Day) 538
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 21,342
  • Open Int (30-Day) 24,925

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0000 +11.00%
on 07/19/21
1.2500 -11.20%
on 07/29/21
-0.1000 (-8.26%)
since 07/02/21
3-Month
0.9900 +12.12%
on 05/13/21
1.5500 -28.39%
on 06/11/21
-0.0700 (-5.93%)
since 05/03/21
52-Week
0.4305 +157.84%
on 11/02/20
3.4800 -68.10%
on 02/11/21
+0.0300 (+2.78%)
since 08/03/20

Most Recent Stories

More News
Results of Celsion's OVATION 1 Study with GEN-1 in Patients with Advanced Ovarian Cancer Published in the Journal of Clinical Cancer Research

Data show dose-dependent suppression of immune-suppressive agents

CLSN : 1.1000 (-1.79%)
Celsion Reports Data Safety Monitoring Board Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer

OVATION 2 Study is 50% Enrolled; Excellent R0 Surgical Resection Noted

CLSN : 1.1000 (-1.79%)
Celsion Corporation Expands Vaccine Advisory Board with the Addition of Dr. Dan H. Barouch and Dr. Luke D. Handke

VAB member experience with vaccine research and immunology will guide development of the PLACCINE platform

CLSN : 1.1000 (-1.79%)
Celsion GmbH Announces Commencement of Enrollment in Oxford University's Phase 1 Study with ThermoDox(R) and Focused Ultrasound in Pancreatic Cancer

Celsion Corporation (NASDAQ: CLSN), Celsion GmbH, a wholly owned subsidiary of Celsion Corporation, a clinical-stage biotechnology company, announces commencement of enrollment in Oxford University's Phase...

CLSN : 1.1000 (-1.79%)
Celsion Corporation Establishes Wholly Owned Subsidiary to Manage Investigator-Sponsored Development of ThermoDox(R)

Celsion GmbH will manage current and future cancer studies with ThermoDox

CLSN : 1.1000 (-1.79%)
Celsion Corporation Enters into $10 Million Strategic Loan Facility with Silicon Valley Bank

Improvement to the Balance Sheet Leverages Strong Equity Structure

CLSN : 1.1000 (-1.79%)
Do Options Traders Know Something About Celsion (CLSN) Stock We Don't?

Investors need to pay close attention to Celsion (CLSN) stock based on the movements in the options market lately.

CLSN : 1.1000 (-1.79%)
Celsion Appoints Christine A. Pellizzari to its Board of Directors

Brings extensive biopharmaceutical legal background to the Board

CLSN : 1.1000 (-1.79%)
INSM : 23.99 (-0.58%)
Celsion Corporation Appoints Dr. Stacy R. Lindborg to its Board of Directors

25-year pharmaceutical industry executive brings broad drug development perspective

CLSN : 1.1000 (-1.79%)
CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING

A Quorum Has Been Achieved to Reconvene Annual Meeting on Thursday June 10, 2021

CLSN : 1.1000 (-1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the...

See More

Key Turning Points

3rd Resistance Point 1.1765
2nd Resistance Point 1.1532
1st Resistance Point 1.1366
Last Price 1.1000
1st Support Level 1.0967
2nd Support Level 1.0734
3rd Support Level 1.0568

See More

52-Week High 3.4800
Fibonacci 61.8% 2.3151
Fibonacci 50% 1.9553
Fibonacci 38.2% 1.5954
Last Price 1.1000
52-Week Low 0.4305

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar